Deanol pidolate

Deanol pidolate (V0191; DMAE pidolate) is an orally active pro-cholinergic agent that improves cognitive symptoms by increasing the release of acetylcholine (Ach) and avoids the typical side effects of cholinesterase inhibitors. Deanol pidolate can alleviate the harmful effects of scopolamine on long-term memory and restore to baseline levels more quickly. Deanol pidolate can be used in research on Alzheimer's disease[1].

Product Specifications

CAS Number

[23513-72-6]

Product Name Alternative

V0191; DMAE pidolate; DMAE PCA

UNSPSC

12352005

Target

MAChR

Related Pathways

GPCR/G Protein; Neuronal Signaling

Field of Research

Neurological Disease

Smiles

O=C(O)[C@H](CC1)NC1=O.CN(CCO)C

Molecular Formula

C9H18N2O4

Molecular Weight

218.25

References & Citations

[1]Dubois B, et al. Effect of six months of treatment with V0191 in patients with suspected prodromal Alzheimer's disease. J Alzheimers Dis. 2012;29 (3) :527-35.